We are live on ! Find out more
JGUA

John G. Ullman & Associates Portfolio holdings

AUM $754M
1-Year Est. Return 60.05%
This Fund
S&P 500
This Quarter Est. Return
-0.64%
1 Year Est. Return
+60.05%
3 Year Est. Return
+108.28%
5 Year Est. Return
+118.76%
10 Year Est. Return
+308.24%
AUM
$722M
AUM Growth
-$5.37M
Cap. Flow
+$9.35M
Cap. Flow %
1.3%
Top 10 Hldgs %
34.36%
Holding
174
New
12
Increased
38
Reduced
77
Closed
6

Top Buys

Rank Stock Value
1
MCO icon
Moody's
MCO
+$4.85M
2
ARCB icon
ArcBest
ARCB
+$3.28M
3
RIVN icon
Rivian
RIVN
+$2.68M
4
APTV icon
Aptiv
APTV
+$2.38M
5
MMM icon
3M
MMM
+$2.33M

Sector Composition

Rank Sector Weight
1 Technology 24.31%
2 Healthcare 22.21%
3 Utilities 18.27%
4 Industrials 17.38%
5 Energy 5.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TMO icon
26
Thermo Fisher Scientific
TMO
$214B
$10.4M 1.44%
17,544
-122
-0.7% -$70.1K
LNN icon
27
Lindsay Corp
LNN
$1.17B
$9.92M 1.37%
63,180
-300
-0.5% -$41.4K
NJR icon
28
New Jersey Resources
NJR
$5.53B
$9.33M 1.29%
203,490
-38,425
-16% -$1.6M
TSM icon
29
TSMC
TSM
$2.17T
$8.82M 1.22%
84,644
-365
-0.4% -$42.7K
FLS icon
30
Flowserve
FLS
$10B
$8.05M 1.12%
224,140
+6,500
+3% +$212K
TMP icon
31
Tompkins Financial
TMP
$1.44B
$8.01M 1.11%
102,339
-800
-0.8% -$64.5K
HON icon
32
Honeywell
HON
$76.3B
$7.12M 0.99%
38,822
-345
-0.9% -$63.8K
HZNP
33
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.04M 0.98%
66,902
-1,625
-2% -$158K
AVGO icon
34
Broadcom
AVGO
$2T
$6.85M 0.95%
108,810
-570
-0.5% -$33.9K
ACM icon
35
Aecom
ACM
$9.63B
$6.67M 0.92%
86,892
-566
-0.6% -$41.6K
AQN icon
36
Algonquin Power & Utilities
AQN
$4.43B
$6.56M 0.91%
422,747
-45,950
-10% -$663K
CACI icon
37
CACI
CACI
$13.9B
$6.25M 0.87%
20,761
-300
-1% -$82.8K
NXST icon
38
Nexstar Media Group
NXST
$5.74B
$6.06M 0.84%
32,150
-400
-1% -$69.6K
ELAN icon
39
Elanco Animal Health
ELAN
$12.1B
$5.58M 0.77%
213,900
-172,375
-45% -$4.59M
LITE icon
40
Lumentum
LITE
$65.2B
$5.46M 0.76%
55,943
-100
-0.2% -$9.78K
IDA icon
41
Idacorp
IDA
$8.15B
$5.06M 0.7%
43,843
-200
-0.5% -$21.8K
MCO icon
42
Moody's
MCO
$81.9B
$4.87M 0.67%
+14,425
New +$4.85M
COHR icon
43
Coherent
COHR
$65.4B
$4.81M 0.67%
66,350
-700
-1% -$47.6K
FISV
44
Fiserv Inc
FISV
$28.9B
$4.6M 0.64%
45,400
+3,350
+8% +$339K
VZ icon
45
Verizon
VZ
$195B
$4.13M 0.57%
81,168
-3,633
-4% -$192K
GVA icon
46
Granite Construction
GVA
$5.32B
$4.13M 0.57%
125,909
-3,184
-2% -$110K
CCK icon
47
Crown Holdings
CCK
$13.2B
$3.78M 0.52%
30,254
-50
-0.2% -$5.91K
ABT icon
48
Abbott
ABT
$187B
$3.7M 0.51%
31,264
-160
-0.5% -$19.8K
ITRI icon
49
Itron
ITRI
$4.5B
$3.59M 0.5%
68,106
+3,605
+6% +$202K
UCTT
50
Ultra Clean Holdings
UCTT
$3.76B
$3.54M 0.49%
83,404
+22,000
+36% +$1.05M

Similar funds

John G. Ullman & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, John G. Ullman & Associates held 174 positions worth $722M, down 0.74% from $727M the previous quarter. Its ten largest holdings account for 34% of the portfolio.

John G. Ullman & Associates's Q1 2022 filing shows 12 new, 38 increased, 77 reduced and 6 closed positions. Its largest new stake was Moody's: 14,425 shares worth $4.87M. The largest sale was Elanco Animal Health, an estimated $4.59M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 26% a quarter earlier, followed by Healthcare and Utilities.

  • John G. Ullman & Associates's largest Q1 2022 buy was Moody's: 14,425 shares worth $4.87M.
  • John G. Ullman & Associates added most to 3M in Q1 2022, an estimated $2.33M increase.
  • John G. Ullman & Associates's biggest Q1 2022 reduction was Elanco Animal Health, cutting an estimated $4.59M.
  • John G. Ullman & Associates fully exited Chewy in Q1 2022, selling an estimated $2.85M.
  • John G. Ullman & Associates's ten largest holdings make up 34% of its $722M portfolio in Q1 2022.
  • John G. Ullman & Associates opened 12 new positions and closed 6 in Q1 2022.
  • John G. Ullman & Associates's portfolio value fell 0.74% quarter-over-quarter to $722M.

Based on John G. Ullman & Associates's 13F filing for Q1 2022, filed 29 Apr 2022.